Hyperglycemia induces innate immune activation via increased levels of Toll-like receptor 4 (TLR4), which is associated with the pathogenesis of DR, and the TLR4 genetic polymorphisms in humans are associated with DR risk [18]. The gene discussed is TLR4; the disease is Hyperglycemia.